{"entity":{"id":"numen","kind":"company","name":"Numen","aka":[],"tldr":"Numen is working on earlier cancer detection, with the stated goal of a future without cancer deaths.","summary":"Numen is a San Francisco company in the YC directory under diagnostics, machine learning and biotech, with the one-line mission of engineering a future without cancer deaths. Its public materials describe early-detection work but give little technical detail, so mechanism and evidence are not recorded here. The YC directory lists it at growth stage with a team of about 18. Included because cancer detection is its stated purpose; treat the record as thin until the company publishes more.","asOf":"2026-09-10","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/numen"},{"label":"Official website","url":"https://www.numen.com"}],"tags":["yc"],"related":[],"cancers":[],"sections":["early-detection","diagnostics"],"technologies":["mced","liquid-biopsy"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"hq":"San Francisco, CA","country":"US","companyType":"diagnostics","website":"https://www.numen.com","stage":"growth","ycBatch":"S23","investors":["y-combinator"],"funding":[]},"route":"/companies/numen/","neighbours":{"section":[{"id":"diagnostics","kind":"section","name":"Diagnostics & Biomarkers","route":"/fronts/diagnostics/"},{"id":"early-detection","kind":"section","name":"Early Detection & Screening","route":"/fronts/early-detection/"}],"technology":[{"id":"liquid-biopsy","kind":"technology","name":"Liquid biopsy (ctDNA)","route":"/technologies/liquid-biopsy/"},{"id":"mced","kind":"technology","name":"Multi-cancer early detection (MCED)","route":"/technologies/mced/"}],"company":[{"id":"y-combinator","kind":"company","name":"Y Combinator","route":"/companies/y-combinator/"}]}}